Top Markets
#1 Cortex Cortex +173.96%
#2 Helium Helium +53.83%
#3 GEKKO GEKKO +51.79%
#4 Pons Pons +24.66%
#5 ADO Protocol ADO Protocol +18.06%
#6 o1.exchange o1.exchange +16.40%
#7 Status Status +11.13%
#8 Siren Siren +10.93%
#9 Ontology Gas Ontology Gas +10.14%
#10 Audiera Audiera +9.54%
Coin of the day
Cortex Cortex
Impostazioni
Lingua
ITALIANO
Valuta
USD
Tema
Sopharma AD Sopharma AD

Sopharma AD

SPH
Classifica tra le azioni #8637
Sopharma AD, an international pharmaceutical company founded in Sofia,... Sopharma AD, an international pharmaceutical company founded in Sofia, Bulgaria, in 1933, specializes in the research, development, manufacturing, and commercialization of a wide array of healthcare products. Its offerings span medicinal substances, finished drug formulations, veterinary vaccines, infusion solutions, and disposable plastic medical devices for both human and animal health, in addition to food supplements. The company's diverse product portfolio addresses numerous therapeutic categories, including cardiology, gastroenterology, pain management, cough and cold remedies, immunology and dermatology, respiratory conditions (like asthma), neurology and psychiatry, urology, and gynecology. Key products include Carsil for gastrointestinal issues, the analgesic Tempalgin, Tabex for smoking cessation, Tribestan to support sexual system functions, Broncholytin for coughs, the common pain reliever Analgin, Nivalin for peripheral nervous system disorders, and Methylprednisolon for severe allergies and critical medical situations. Beyond its core pharmaceutical business, Sopharma AD engages in a variety of other ventures. These include providing secondary packaging services for pharmaceuticals, leasing real estate, and operating in the retail sector for medicines and medical equipment. The company also handles the cultivation, collection, and trade of herbs and medicinal plants. Furthermore, it is involved in the trading, transport, and packaging of radioactive materials and nuclear equipment for medical applications, as well as household electronics and electrical equipment. Sopharma AD also offers market and public opinion research, provides franchising and know-how, and participates in various consulting and non-pharmaceutical activities, such as the production of veterinary vaccines and infusion solutions.
Prezzo delle azioni
$2.28
Ultima sincronizzazione: 2026-08-27
Capitalizzazione di mercato
$1.20B
Variazione (1 giorno)
2.53%
Variazione (1 anno)
-34.74%
Paese
BG
Scambia Sopharma AD (SPH)

Categoria

Healthcare
Utile per Sopharma AD (SPH)
Utile nel 2026 TTM: 0
Secondo gli ultimi rapporti finanziari di Sopharma AD, gli utili attuali della società sono 0. Nel 2026, la società ha registrato un utile di 0, uguale a agli utili del 2026, che erano di 0. Gli utili mostrati in questa pagina sono quelli prima degli interessi e delle imposte, ovvero EBIT.
Storico degli utili di Sopharma AD dal 2026 al 2026
Utile alla fine di ogni anno
Anno Utile Cambia
Non abbastanza dati per le date fornite.
Utile per aziende simili o concorrenti
Azienda Utile Differenza negli utili Il paese
McKesson Corporation McKesson Corporation
McKesson Corporation
MCK.US
$6.46B -
US
Cencora, Inc. Cencora, Inc.
Cencora, Inc.
COR.US
- -
US
Cardinal Health, Inc. Cardinal Health, Inc.
Cardinal Health, Inc.
CAH.US
$2.17B -
US
AmerisourceBergen Corporation AmerisourceBergen Corporation
AmerisourceBergen Corporation
ABC.US
- -
US
Sigma Healthcare Limited Sigma Healthcare Limited
Sigma Healthcare Limited
SIG.AX
$708.86M -
AU